Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01351545 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

StatusRecruiting
PhaseNot specified
Started2011-10
View on ClinicalTrials.gov ↗

Amendment history

The 50 most recent of 241 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

2026-07-01
minor
Study Status, Contacts/Locations v240
Study sitescontacts updated at 2 of 142 sites
2026-06-02
minor
Study Status, Contacts/Locations v239
Study sitesdetails revised at 17 of 142 sites
2026-04-07
minor
Study Status, Contacts/Locations v238
Study sites142 entries, revised
WesternWest Penn Hospital
2026-02-09
minor
Study Status, Contacts/Locations v237
Study sitesdetails revised at 4 of 142 sites
2025-12-16
minor
Study Status, Contacts/Locations v236
Study sitesdetails revised at 2 of 142 sites
Show 45 earlier versions
2025-11-19
minor
Study Status, Oversight, Contacts/Locations, IPDSharing v235
Study sites141→142
2025-04-15
minor
Study Status, Contacts/Locations v234
Study sitescontacts updated at 115 of 141 sites
2025-04-01
minor
Study Status, Oversight, Contacts/Locations, IPDSharing v233
Study sitesdetails revised at 115 of 141 sites
2025-01-29
minor
2 amendments v231-v232
2 re-verifications since 2025-01-23, no change to tracked fields
2025-01-10
minor
Study Identification, Study Status, Oversight, Contacts/Locations, IPDSharing v230
Study sites140→141
2024-12-12
minor
Study Status, Contacts/Locations v229
Study sitesdetails revised at 1 of 140 sites
2024-11-19
minor
Study Status, Contacts/Locations v228
Study sitesdetails revised at 1 of 140 sites
2024-10-29
minor
Study Status, Contacts/Locations v227
Study sitescontacts updated at 1 of 140 sites
2024-09-19
minor
Study Identification, Study Status, Oversight, Contacts/Locations, IPDSharing v226
Study sitesdetails revised at 118 of 140 sites
2024-06-20
minor
Study Status, Contacts/Locations v225
Study sitesdetails revised at 1 of 140 sites
2024-06-19
minor
Study Status, Contacts/Locations v224
Study sitesdetails revised at 5 of 140 sites
2024-06-10
minor
Study Status, Contacts/Locations v223
Study sitescontacts updated at 1 of 140 sites
2024-05-09
minor
Study Status, Contacts/Locations v222
Study sitesdetails revised at 1 of 140 sites
2024-03-14
minor
Study Status, Contacts/Locations v221
Study sitesdetails revised at 7 of 140 sites
2024-02-14
minor
Study Status, Contacts/Locations v220
Study sitesdetails revised at 4 of 140 sites
2023-12-15
minor
Study Status, Contacts/Locations v219
Study sitesdetails revised at 2 of 140 sites
2023-10-27
minor
Study Status, Contacts/Locations v218
Study sitesdetails revised at 3 of 140 sites
2023-10-06
minor
Study Status, Contacts/Locations v217
Study sitescontacts updated at 5 of 140 sites
2023-09-21
minor
Study Status, Contacts/Locations v216
Study sitesdetails revised at 1 of 140 sites
2023-06-19
minor
Study Status, Contacts/Locations v215
Study sitesdetails revised at 1 of 140 sites
2023-06-15
minor
Study Status, Contacts/Locations v214
Study sitesdetails revised at 1 of 140 sites
2023-05-30
minor
Study Status, Contacts/Locations v213
Study sitesdetails revised at 2 of 140 sites
2023-05-18
minor
Study Status, Contacts/Locations v212
Study sitesdetails revised at 1 of 140 sites
2023-05-03
minor
Study Status, Contacts/Locations v211
Study sitesdetails revised at 1 of 140 sites
2023-04-27
minor
Study Status, Contacts/Locations v210
Study sitesdetails revised at 1 of 140 sites
2023-04-04
minor
Study Status v209
Re-verified, no change to tracked fields
2023-02-27
minor
Study Status, Contacts/Locations v208
Study sitesdetails revised at 1 of 140 sites
2023-02-24
minor
Study Status, Contacts/Locations v207
Study sitesdetails revised at 3 of 140 sites
2023-02-17
minor
Study Status, Contacts/Locations v206
Study sitescontacts updated at 1 of 140 sites
2023-02-02
minor
Study Status, Contacts/Locations v205
Study sites139→140
2023-01-03
minor
Study Status, Contacts/Locations v204
Study sitesdetails revised at 1 of 139 sites
2022-12-14
minor
Study Status, Contacts/Locations v203
Study sitescontacts updated at 1 of 139 sites
2022-12-12
minor
Study Status, Contacts/Locations v202
Study sitesdetails revised at 1 of 139 sites
2022-12-08
minor
Study Status, Contacts/Locations v201
Study sitesdetails revised at 1 of 139 sites
2022-11-17
minor
Study Status, Contacts/Locations v200
Study sitesdetails revised at 2 of 139 sites
2022-11-10
minor
Study Status, Contacts/Locations v199
Study sitescontacts updated at 1 of 139 sites
2022-11-08
minor
Study Status, Contacts/Locations v198
Study sitescontacts updated at 2 of 139 sites
2022-10-04
minor
Study Status, Contacts/Locations v197
Study sitesdetails revised at 2 of 139 sites
2022-09-28
minor
Study Status, Contacts/Locations v196
Study sitesdetails revised at 2 of 139 sites
2022-09-01
minor
Study Status, Contacts/Locations v195
Study sitescontacts updated at 1 of 139 sites
2022-08-01
minor
Study Status, Contacts/Locations v194
Study sitesdetails revised at 1 of 139 sites
2022-07-21
minor
Study Status, Contacts/Locations v193
Study sitesdetails revised at 2 of 139 sites
2022-07-14
minor
Study Status, Contacts/Locations v192
Study sitesdetails revised at 1 of 139 sites
2022-06-24
minor
Study Status, Contacts/Locations v191
Study sitescontacts updated at 1 of 139 sites
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Trial Details
NCT Number NCT01351545
Lead Sponsor Center for International Blood and Marrow Transplant Research
Collaborators: National Marrow Donor Program
Conditions Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML) +9 more
Enrollment 99,999 participants
Start Date 2011-10
Primary Completion 2041-10 (estimated)
Study Completion 2041-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-06